Back
TLRY
HealthcareTilray Brands, Inc.
Next Earnings: Q2 2026
Thursday, January 8, 2026
Loading...
TLRY EPS History & Predictions
Actual
Consensus
Wall Street
$-0.14consensus
GPT-5.2
$-0.18▼
Gemini 3 Pro
$-0.27▼
Claude-opus
$-0.04▲
Grok-4
$-0.02▲
Q2 2026 Predictions
AI analyst forecasts for the upcoming earnings release. Click a model to see its reasoning.
GPT-5.2
openrouterEPS
$-0.18
Revenue
$0.20B
Conf.
42%Click for details →
Gemini 3 Pro
openrouterEPS
$-0.27
Revenue
$0.32B
Conf.
85%Click for details →
Claude-opus
openrouterEPS
$-0.04
Revenue
$0.28B
Conf.
72%Click for details →
Grok-4
openrouterEPS
$-0.02
Revenue
$0.30B
Conf.
85%Click for details →
Predictions Comparison
AI model predictions compared to Wall Street consensus
| Model | EPS Estimate | Revenue Estimate | vs Consensus | Confidence | |
|---|---|---|---|---|---|
GPT-5.2openrouter | $-0.18 | $0.20B | +28.6% | 42% | |
Gemini 3 Proopenrouter | $-0.27 | $0.32B | +92.9% | 85% | |
Claude-opusopenrouter | $-0.04 | $0.28B | -71.4% | 72% | |
Grok-4openrouter | $-0.02 | $0.30B | -85.7% | 85% | |
| Wall Street Consensus | $-0.14 | $0.21B | — | — |
Quarterly Earnings Surprise Amount
No earnings history available.
Financial Statements
Historical data with AI projections for Q2 2026
All values in Billions (USD) unless otherwise noted
AI Projections | ||||||||
|---|---|---|---|---|---|---|---|---|
| Line Item | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | GPT-5.2Q2 2026 | Gemini 3 ProQ2 2026 | Claude-opusQ2 2026 | Grok-4Q2 2026 |
| Revenue | ||||||||
| Revenue | 0.295 | 0.268 | 0.308 | 0.288 | 0.205-28.8% | 315.80 | 0.275-4.4% | 0.305+6.0% |
| Cost Of Revenue | 0.209 | 0.193 | 0.215 | 0.209 | 0.154-26.3% | 224.20 | 0.201-3.9% | 0.223+6.8% |
| Cost & Gross Profit | ||||||||
| Gross Profit | 0.086 | 0.075 | 0.093 | 0.079 | 0.051-35.4% | 91.60 | 0.074-5.9% | 0.082+3.9% |
| Cost And Expenses | 0.354 | 1.37 | 2.29 | 0.285 | 0.217-23.8% | 351.40 | 0.273-4.3% | 0.301+5.6% |
| Operating Expenses | ||||||||
| Research And Development Expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000+6.5% | 0.000 | 0.000-2.3% | 0.000+6.5% |
| General And Administrative Expenses | 0.065 | 0.057 | 0.050 | 0.057 | 0.040-29.5% | 58.00 | 0.052-8.3% | 0.057-0.0% |
| Selling And Marketing Expenses | 0.036 | 0.030 | 0.032 | 0.032 | 0.022-30.6% | 36.50 | 0.030-5.4% | 0.032-0.0% |
| Selling General And Administrative Expenses | 0.101 | 0.087 | 0.082 | 0.088 | 0.062-29.9% | 94.50 | 0.082-7.3% | 0.088-0.5% |
| Other Expenses | 0.043 | 1.09 | 1.99 | -0.012 | -0.008+37.2% | -2.00 | 0.010+180.6% | -0.012+0.1% |
| Operating Expenses | 0.145 | 1.17 | 2.07 | 0.076 | 0.063-17.2% | 116.60 | 0.072-5.3% | 0.078+2.5% |
| Interest Expense | 0.011 | 0.012 | 0.005 | 0.009 | 0.009-4.3% | 10.50 | 0.009-2.2% | 0.009+0.0% |
| Total Other Income Expenses Net | -0.057 | -0.047 | 0.070 | -0.004 | -0.008-98.3% | -12.50 | -0.007-77.9% | -0.015-268.6% |
| Income Tax Expense | 0.003 | 0.002 | -0.172 | -0.003 | -0.001+68.1% | 1.20 | -0.001+84.1% | -0.003+1.2% |
| Other Income/Expense | ||||||||
| Net Interest Income | -0.011 | -0.012 | -0.005 | -0.009 | -0.009+4.3% | -10.50 | -0.009+2.2% | -0.009-0.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non Operating Income Excluding Interest | 0.047 | 0.035 | -0.091 | -0.005 | 0.001+119.0% | -2.00 | -0.002+62.0% | -0.005-0.7% |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income & EPS | ||||||||
| Operating Income | -0.059 | -1.10 | -1.98 | 0.003 | -0.012-517.6% | -25.00 | 0.002-21.7% | 0.004+39.2% |
| Income Before Tax | -0.116 | -1.14 | -1.91 | -0.001 | -0.020 | -37.50 | -0.005-347.9% | -0.005-390.4% |
| Net Income From Continuing Operations | -0.119 | -1.15 | -1.74 | 0.002 | -0.019 | -38.70 | -0.004-304.5% | -0.002-201.0% |
| Net Income From Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -0.119 | -1.14 | -1.75 | -0.000 | -0.019 | -38.70 | -0.004-860.9% | -0.002-374.8% |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bottom Line Net Income | -0.119 | -1.14 | -1.75 | -0.000 | -0.019 | -38.70 | -0.004-860.9% | -0.002-374.8% |
| Eps | -$1.40 | -$12.60 | -$17.80 | -$0.0040 | -$0.1800 | -$0.2700 | -$0.0400-900.0% | -$0.0200-400.0% |
| Eps Diluted | -1.40 | -12.60 | -17.80 | -0.00 | -0.18 | -0.27 | -0.04-900.0% | -0.02-400.0% |
| Other | ||||||||
| Filing Date | 0.000 | 0.000 | 0.000 | 0.000 | — | — | — | — |
| Fiscal Year | 0.000 | 0.000 | 0.000 | 0.000 | — | — | — | — |
| Depreciation And Amortization | 0.048 | 0.048 | 0.047 | 0.021 | 0.020-6.4% | 22.00 | 0.020-6.4% | 0.021+0.1% |
| Ebitda | -0.058 | -1.08 | -1.84 | 0.030 | 0.009-69.5% | -5.00 | 0.024-17.8% | 0.026-12.6% |
| Ebit | -0.106 | -1.13 | -1.89 | 0.008 | -0.011-235.2% | -27.00 | 0.004-47.8% | 0.004-45.9% |
| Weighted Average Shs Out | 86,497,500 | 90,834,300 | 97,796,000 | 106,027,189 | 106,000,000-0.0% | 114 | 108,000,000+1.9% | 106,000,000-0.0% |
| Weighted Average Shs Out Dil | 86,497,500 | 90,834,300 | 97,796,000 | 106,027,189 | 106,000,000-0.0% | 114 | 108,000,000+1.9% | 106,000,000-0.0% |